PRAX
Praxis Precision Medicines, Inc.
NASDAQ · Healthcare · Biotechnology · US
$351.81
−0.94%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-25.3%
Return on equity
-24.4%
Return on assets
-28.2%
Return on invested capital
0.00x
Asset turnover
-$305.7M
Cash from operations
$27
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026